We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Heart Failure Risk Outweighs Stroke in CKD Patients

By HospiMedica International staff writers
Posted on 03 Jan 2017
Chronic kidney disease (CKD) patients are at a risk of heart failure (HF) that is as high as for coronary heart disease (CHD), whereas stroke risk is only slightly elevated, according to a new study.

Researchers at the University of Washington (UW; Seattle, USA), Tufts Medical Center (Boston, MA, USA), and other institutions conducted a study to determine absolute rates and comparative risk differences of incident HF, CHD, and stroke in CKD patients. More...
In all, 14,462 participants were pooled from three studies: the Jackson Heart Study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis. Main outcome and measures were incidence rates (IRs) and risk differences comparing participants with and without CKD.

The results revealed that CKD patients had a 2.3 per 1,000 person-year greater risk than those without CKD for both HF and CHD. For stroke, the risk difference was 0.8 per 1,000 per person-year in CKD, versus no CKD. Risks were particularly high for African American and Hispanic participants, with adjusted risk differences in those with CKD for HF of 3.5 and 7.8 per 1,000 person-years, respectively. The study was published on December 21, 2016, in JAMA Cardiology.

“Cardiovascular disease is the leading cause of morbidity and mortality in patients with CKD. Understanding the relative contributions of cardiovascular disease event types to the excess burden of cardiovascular disease is important for developing effective strategies to improve outcomes,” concluded lead author Nisha Bansal, MD, MAS, of the UW Kidney Research Institute, and colleagues. “The excess risk of HF associated with CKD was particularly large among African American and Hispanic individuals. Efforts to improve health outcomes for patients with CKD should prioritize HF in addition to CHD prevention.”

CKD is the progressive loss of kidney function over a period of months or years, identified by the presence of creatinine, a breakdown product of muscle metabolism. Higher levels of creatinine indicate a lower glomerular filtration rate (GFR), resulting in a decreased capability of the kidneys to excrete waste products. Symptoms are not specific, and might include feeling generally unwell or a reduced appetite. Professional guidelines classify severity of CKD in five stages, culminating in end- end-stage renal disease (ESRD), a severe illness with poor life expectancy if left untreated.

Related Links:
University of Washington
Tufts Medical Center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.